Anaxsys is a medical device company that develops and markets innovative respiratory devices. Their unique approach to identifying and meeting clinical needs has resulted in a range of novel products, based on patented sensor technology, to improve patient outcomes. These product ranges are targeted at patient monitoring, screening and diagnostics in the areas of vital signs, sleep apnoea, asthma and lung cancer. Anaxsys’ first product to market is respiR8, a continuous respiratory rate counter that provides an early indication of patient deterioration.